Synucleozid-2.0 is a blood-brain barrier-permeable inhibitor that binds to the IRE of SNCA mRNA, with a EC50 of 2.9 µM and a Kd value of 1.8 µM. Synucleozid-2.0 selectively binds to and stabilizes the A bulge and adjacent closed base pairs in the 5 UTR IRE of SNCA mRNA, blocks the translation process and reduces intracellular levels of alpha-synuclein. Synucleozid-2.0 exerts cytoprotective effects against cytotoxicity induced by alpha-synuclein preformed fibrils. Synucleozid-2.0 is applicable to the research of Parkinsons disease[1].
Molekulargewicht:
506.38
CAS Nummer:
[613226-91-8]
Formel:
C22H16BrN7OS
Target-Kategorie:
DNA/RNA Synthesis,alpha-synuclein
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten